HOME >> MEDICINE >> NEWS
DepoDur found to be innovative option for postoperative pain relief

CHADDS FORD, Pa., October 26, 2004 Data from two clinical trials presented at the American Society of Anesthesiologists' Annual Meeting in Las Vegas this week support the safety and efficacy of DepoDurTM (morphine sulfate extended-release liposome injection) CII -- an innovative single-dose epidural injection designed to improve postoperative pain control. DepoDurTM will be commercially available in the U.S. by the end of 2004.

DepoDurTM was approved by the U.S. Food and Drug Administration (FDA) in May 2004 for the treatment of pain following major surgery. It is given as a single epidural injection before or during surgery in procedures such as hip and knee replacement, lower abdominal surgery and elective Caesarean section. Unlike currently available epidural morphine formulations, DepoDurTM can provide up to 48 hours of effective pain relief with a single shot. Furthermore, DepoDurTM does not require an indwelling catheter for continuous infusion, which may limit patient mobility and present obstacles for administering anticoagulant (blood thinning) therapy. This new therapeutic option may help physicians overcome challenges associated with current postoperative pain treatment options while providing safe and effective pain control.

"DepoDurTM has been shown to offer effective pain control while streamlining the process of peri-operative pain management," said Gavin Martin, M.D., assistant clinical professor of anesthesiology, Duke University and an investigator in clinical trials. "Soon patients will be able to experience up to 48 hours of pain relief post-surgery with a single shot. This product will help enable healthcare professionals to achieve optimal pain control for their patients without the many challenges commonly associated with postoperative pain relief."

The majority of surgical patients experience moderate-to-severe postoperative pain, but the treatmen
'"/>

Contact: Wendy Lu
wendy_lu@nyc.cohnwolfe.com
212-798-9839
Cohn & Wolfe
26-Oct-2004


Page: 1 2 3 4 5 6 7

Related medicine news :

1. Acupuncture found to lower elevations in blood pressure
2. Proteins found in urine of pregnant women could help diagnose preeclampsia
3. Potential drug target for treating cocaine abuse found
4. Similar results found in both older and younger patients undergoing weight-loss surgery
5. Infectious agent linked to mad cow disease found in organs other than the brain
6. Generation gap found in chronic pain
7. A site for sore eyes: New target for allergies found under the eyelid
8. Chemicals found in cherries may help fight diabetes
9. Thanks for the memories: cinematic portrayal of amnesia is profoundly misleading
10. Very high prevalence of virus linked to cervical cancer found in adolescent women
11. Two-fisted assault on dopamine transport system may be foundation of Parkinsons disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DepoDur found innovative option for postoperative pain relief

(Date:3/2/2015)... March 02, 2015 Four Seasons Resort Maui ... its 25th anniversary this year, having officially opened its doors ... luxury resort is honoring over 70 employees who started on ... from amongst the approximately 400 original employees. The celebration ... Oceanfront Lawn. , This Four Seasons flagship resort, ...
(Date:3/2/2015)... Dhaka, Bangladesh (PRWEB) March 02, 2015 ... appointment of fire safety expert Mark Chubb to serve ... oversee fire safety operations and training in Bangladesh and ... Members source. , “Mark will ensure that the ... and fire safety programs for Bangladesh garment workers,” said ...
(Date:3/2/2015)... 02, 2015 Secura Consultants announced ... with First Protective Insurance Group of Birmingham, AL ... First Protective affiliated advisors to access the enhanced ... Secura Consultants delivers. , Secura Consultants, ... in the design and implementation of insured income ...
(Date:3/1/2015)... Birmingham, Clarkston, Lake Orion, Metamora, Michigan (PRWEB) March 01, 2015 ... BOTOX® , which is approved to treat Overactive Bladder (OAB) ... urgency and frequency in adults when another type of medication ... This is a different treatment option that takes another ... itself. , BOTOX® works on the nerves and ...
(Date:3/1/2015)... Chicago, IL (PRWEB) March 01, 2015 Ticket ... Grateful Dead in Chicago at Soldier Field. Deadheads ... was announced in January. , Grateful Dead was formed 50 ... and they were together as one until the untimely death ... known for combining different genres including blues, reggae, rock, bluegrass, ...
Breaking Medicine News(10 mins):Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2
(Date:3/2/2015)... DUBLIN , Mar. 02, 2015 Research ... announced the addition of the "Lopinavir - ... , Imagine having your own ... of a button. Used by the ... over 10 years, these searches are the benchmark ...
(Date:3/2/2015)... 2015  SI-BONE, Inc., a medical device company that ... of the sacroiliac (SI) joint with the iFuse Implant ... procedures have now been performed world wide utilizing more ... the iFuse procedure continues to grow and gain momentum ... the United States and 17 ...
(Date:3/2/2015)... 2015 Shire plc (LSE: SHP, NASDAQ: ... submitted a New Drug Application (NDA) with the U. S. ... the treatment of signs and symptoms of dry eye disease ... first treatment indicated to address both the signs and symptoms ... millions of people," said Philip J. Vickers , Ph.D., ...
Breaking Medicine Technology:Global Comprehensive Lopinavir Patent Search Online Portal 2015 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 3Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 2Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 3Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 4
Cached News: